New Indication Approved for Yallaferon® 2005.09.07

 
(Hong Kong, 7 September 2005) - Lee's Pharmaceutical Holdings Limited (GEM) Stock: 8221; Website: www.leespharm.com) announced today that Yallaferon® (Recombinant Human Interferon α-2b gel) has been approved for an additional indication for use in the treatment of herpes zoster by the SFDA of China.
 


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD